Literature DB >> 32417325

HMGB1 promoted P-glycoprotein at the blood-brain barrier in MCAO rats via TLR4/NF-κB signaling pathway.

Fei Wang1, Shenglan Ji2, Muxi Wang3, Lu Liu2, Qiaoling Li2, Fuxia Jiang2, Juan Cen4, Biansheng Ji5.   

Abstract

P-glycoprotein (P-gp) is located on the luminal surface of brain vascular endothelium and its status may determine the delivery of the agents into the brain tissues. Previous study showed that upregulation of P-gp at the blood-brain barrier (BBB) after ischemic stroke were mediated by nuclear factor-B (NF-kB) and tumour necrosis factor-α (TNF-α). Based on middle cerebral artery occlusion (MCAO) rats and oxygen-glucose deprivation (OGD) in co-culture of rat brain microvessel endothelial cells (rBMECs) and astrocytes system, the present data indicated that potentiated P-gp expression and activity in brain microvessels or rBMECs were associated with the increase in high-mobility group box 1 (HMGB1), Toll-like receptor 4 (TLR4) and activation of NF-kB and that HMGB1 can release from nucleus to the cytoplasm in activated astrocytes, then into the medium. Moreover, changes in TLR4, TIR domain-containing adaptor protein (TIRAP), NF-kB and P-gp in rBMECs were attenuated by addition of 1 mM ethyl pyruvate (EP), 10 μM TAK-242 and 10 μM pyrrolidine dithiocarbamate (PDTC), respectively. These results demonstrated that HMGB1 promoted P-gp at the BBB after cerebral ischemia via TLR4/NF-κB signaling pathway.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Blood-brain barrier; HMGB1; Middle cerebral artery occlusion; P-glycoprotein

Mesh:

Substances:

Year:  2020        PMID: 32417325     DOI: 10.1016/j.ejphar.2020.173189

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  6 in total

1.  Loss of TLR4 in endothelial cells but not Müller cells protects the diabetic retina.

Authors:  Adam Seidel; Li Liu; Youde Jiang; Jena J Steinle
Journal:  Exp Eye Res       Date:  2021-03-28       Impact factor: 3.467

Review 2.  The Effect and Regulatory Mechanism of High Mobility Group Box-1 Protein on Immune Cells in Inflammatory Diseases.

Authors:  Yun Ge; Man Huang; Yong-Ming Yao
Journal:  Cells       Date:  2021-04-28       Impact factor: 6.600

Review 3.  High Mobility Group Box-1 and Blood-Brain Barrier Disruption.

Authors:  Masahiro Nishibori; Dengli Wang; Daiki Ousaka; Hidenori Wake
Journal:  Cells       Date:  2020-12-10       Impact factor: 6.600

4.  Paeonol Protects Against Methotrexate-Induced Nephrotoxicity via Upregulation of P-gp Expression and Inhibition of TLR4/NF-κB Pathway.

Authors:  Mohamed A Morsy; Azza A K El-Sheikh; Sara Mohamed Naguib Abdel-Hafez; Mahmoud Kandeel; Seham A Abdel-Gaber
Journal:  Front Pharmacol       Date:  2022-02-04       Impact factor: 5.810

Review 5.  Factors not considered in the study of drug-resistant epilepsy: Drug-resistant epilepsy: Assessment of neuroinflammation.

Authors:  Patricia Campos-Bedolla; Iris Feria-Romero; Sandra Orozco-Suárez
Journal:  Epilepsia Open       Date:  2022-03-16

6.  TLR4 contributes to the damage of cartilage and subchondral bone in discectomy-induced TMJOA mice.

Authors:  Xin Liu; Heng-Xing Cai; Pin-Yin Cao; Yaping Feng; Heng-Hua Jiang; Li Liu; Jin Ke; Xing Long
Journal:  J Cell Mol Med       Date:  2020-09-11       Impact factor: 5.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.